Target intelligence / Profile preview

Bacterial biofilm matrix and extracellular proteases

Molecular classification
Enzyme, Complex biological assembly, Polysaccharide, Extracellular matrix component
01

Overview

The bacterial biofilm matrix, primarily composed of the extracellular polymeric substance (EPS), serves as a protective scaffold for microbial communities in chronic wounds (Flemming & Wingender, 2010, Nature Reviews Microbiology). This matrix consists of polysaccharides, extracellular DNA (eDNA), and proteins that shield bacteria from host immune responses and antibiotic penetration (Percival et al., 2015, Wound Repair and Regeneration). Concurrently, bacteria within the biofilm secrete extracellular proteases, such as elastases and collagenases, which degrade host tissue and essential growth factors, thereby stalling the wound healing process (Gibson et al., 2009, Journal of Wound Care). Therapeutic targeting of this environment involves the use of agents like collagenase clostridium histolyticum or cadexomer iodine to physically disrupt the EPS and neutralize bacterial enzymes (Schultz et al., 2017, Wound Repair and Regeneration). By degrading these structural and functional components, treatments aim to reduce the microbial burden and transition the wound from a chronic inflammatory state to an active healing phase.

Other names
Extracellular polymeric substanceEPSBiofilm matrixMicrobial extracellular proteasesWound biofilm environment
02

Mechanism of action

Enzymatic degradation of the extracellular polymeric substance (EPS) and inhibition of bacterial-derived proteolytic enzymes to disrupt biofilm integrity and promote wound healing.

03

Biological functions

Structural supportImmune evasionTissue degradationNutrient sequestration
04

Disease associations

InfectionChronic woundDiabetic foot ulcerPressure ulcer
05

Safety considerations

Non-specific degradation of host extracellular matrixIrritation of periwound skinPotential for systemic toxicity from topical agentsDelayed epithelialization
06

Interacting drugs

Collagenase clostridium histolyticum

5 more in the full profile.

07

Biomarkers

Extracellular DNA (eDNA) levelsMatrix metalloproteinase (MMP) activityBacterial loadBiofilm-associated protein (Bap)

Beyond the preview

Go deeper on Bacterial biofilm matrix and extracellular proteases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial biofilm matrix and extracellular proteases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call